Targeted delivery of doxorubicin using RSV F-protein modified breast cancer-derived exosomes in breast cancer-bearing mice

Narges Mardi, Amir Zarebkohan, Cigir Biray-Avci, Reza Rahbarghazi, Mehdi Talebi, Hamid Lotfimehr, Sharareh Khavandkari, Zahra Abbasi-Malati, Nastaran Sedghi-Samarkhazan, Elham Shahriyari, Asghar Khalilnezhad, Morteza Milani, Mohammad Nouri

Open source

DOI
10.34172/bi.33180
Published
2026-06-15
Container
BioImpacts
Publisher
Maad Rayan Publishing Company
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.34172/bi.33180,
  title = {Targeted delivery of doxorubicin using RSV F-protein modified breast cancer-derived exosomes in breast cancer-bearing mice},
  author = {Narges Mardi and Amir Zarebkohan and Cigir Biray-Avci and Reza Rahbarghazi and Mehdi Talebi and Hamid Lotfimehr and Sharareh Khavandkari and Zahra Abbasi-Malati and Nastaran Sedghi-Samarkhazan and Elham Shahriyari and Asghar Khalilnezhad and Morteza Milani and Mohammad Nouri},
  year = {2026},
  journal = {BioImpacts},
  doi = {10.34172/bi.33180},
  url = {https://doi.org/10.34172/bi.33180}
}

RIS

TY  - JOUR
TI  - Targeted delivery of doxorubicin using RSV F-protein modified breast cancer-derived exosomes in breast cancer-bearing mice
AU  - Narges Mardi
AU  - Amir Zarebkohan
AU  - Cigir Biray-Avci
AU  - Reza Rahbarghazi
AU  - Mehdi Talebi
AU  - Hamid Lotfimehr
AU  - Sharareh Khavandkari
AU  - Zahra Abbasi-Malati
AU  - Nastaran Sedghi-Samarkhazan
AU  - Elham Shahriyari
AU  - Asghar Khalilnezhad
AU  - Morteza Milani
AU  - Mohammad Nouri
PY  - 2026
JO  - BioImpacts
DO  - 10.34172/bi.33180
UR  - https://doi.org/10.34172/bi.33180
ER  - 

APA

Mardi, N., Zarebkohan, A., Biray-Avci, C., Rahbarghazi, R., Talebi, M., Lotfimehr, H., Khavandkari, S., Abbasi-Malati, Z., Sedghi-Samarkhazan, N., Shahriyari, E., Khalilnezhad, A., Milani, M., & Nouri, M. (2026). Targeted delivery of doxorubicin using RSV F-protein modified breast cancer-derived exosomes in breast cancer-bearing mice. BioImpacts. https://doi.org/10.34172/bi.33180

Source records